MARK LIN: Open Payments
NPI 1821762600 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 11 payments from 10 companies in 2025. Trend: 2023 $197 · 2024 $429 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Genentech USA, Inc. | 1 | $31 |
| SERVIER PHARMACEUTICALS LLC | 1 | $28 |
| Incyte Corporation | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $25 |
| Aveo Pharmaceuticals, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| BSN Medical Inc | 1 | $17 |
Products named: KEYTRUDA, ICLUSIG, Itovebi, Tibsovo, JAKAFI, Zoladex, FOTIVDA, Nubeqa.
Industry payments across FL — which companies pay providers there.
